07 August 2013

Mead Johnson settles over baby formula probe

Mead Johnson Nutrition said it will pay a penalty of about $33 million related to a probe by China into anti-competitive behaviour.


Mead Johnson Nutrition Co on Tuesday said it will pay a penalty of about $33 million related to a probe by China into anti-competitive behaviour by baby formula makers.

The maker of Enfamil formula said the payment will reduce its full-year earnings by about 12 cents per share. But it reiterated its 2013 earnings forecast for profit, excluding one-time items, of $3.22 (±R32.20) to $3.30 (±R33.00) per share.

Mead Johnson, along with Danone, Nestle, Abbott Laboratories and Hong Kong-listed Biostime International Holdings said in recent weeks that they were being investigated by China's National Development and Reform Commission, an economic planning agency, for possible antitrust violations, including price-fixing.

As a result, Mead Johnson and others cut prices on their baby formulas.

Foreign infant formula is highly coveted in China since public trust was damaged by a 2008 tainted infant formula scandal that left at least six children dead. Foreign brands now account for about half of total sales.


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Live healthier

Smoking dangers »

Hubbly hooking lots of young adults on tobacco Hookah smokers are inhaling benzene Many young adults misinformed about hookahs

Hookah pipes far from harmless, study warns

In addition to toxic substances from tobacco and nicotine, hookah smoke exposes users to charcoal combustion products, including large amounts of carbon monoxide.

Managing incontinence »

5 avoidable triggers that can make urinary incontinence worse

Urinary incontinence is a manageable condition – here are a few common triggers of urinary leakage.